A detailed history of Kepos Capital LP transactions in Pfizer Inc stock. As of the latest transaction made, Kepos Capital LP holds 150,000 shares of PFE stock, worth $4.2 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares
150,000
Previous 100,000 50.0%
Holding current value
$4.2 Million
Previous $2.88 Million 44.6%
% of portfolio
1.07%
Previous 0.93%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $1.29 Million - $1.49 Million
50,000 Added 50.0%
150,000 $4.16 Million
Q4 2023

Feb 12, 2024

BUY
$26.13 - $33.94 $2.61 Million - $3.39 Million
100,000 New
100,000 $2.88 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $3.18 Million - $3.73 Million
-100,000 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$30.12 - $36.54 $3.01 Million - $3.65 Million
100,000 New
100,000 $3.27 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $920,048 - $1.04 Million
-27,948 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $908,030 - $1.18 Million
27,948 New
27,948 $1 Million
Q2 2019

Aug 13, 2019

SELL
$36.98 - $41.52 $5.39 Million - $6.05 Million
-145,665 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $286,425 - $314,685
-7,638 Reduced 4.98%
145,665 $6.19 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $3.05 Million - $3.48 Million
79,299 Added 107.16%
153,303 $6.69 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $3.14 Million - $3.81 Million
-91,012 Reduced 55.15%
74,004 $3.26 Million
Q2 2018

Aug 13, 2018

BUY
$32.98 - $35.16 $905,828 - $965,704
27,466 Added 19.97%
165,016 $5.99 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $252,440 - $292,865
7,911 Added 6.1%
137,550 $4.88 Million
Q4 2017

Feb 12, 2018

BUY
$33.26 - $35.29 $4.31 Million - $4.57 Million
129,639
129,639 $4.7 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Kepos Capital LP Portfolio

Follow Kepos Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Kepos Capital LP with notifications on news.